• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓内骨棒治疗中足夏科氏关节病的临床疗效和并发症。

Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming.

机构信息

1 Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC, USA.

2 OrthoCarolina Foot and Ankle Institute, Charlotte, NC, USA.

出版信息

Foot Ankle Int. 2019 Jan;40(1):18-23. doi: 10.1177/1071100718799966. Epub 2018 Oct 4.

DOI:10.1177/1071100718799966
PMID:30284492
Abstract

BACKGROUND

: The purpose of this study was to examine the clinical outcomes and complications of patients with midfoot Charcot managed with midfoot osteotomy, realignment arthrodesis, and stabilization using intramedullary beams.

METHODS

: Consecutive patients with midfoot Charcot treated at a tertiary-care foot and ankle center from January 2013 to July 2016 who underwent corrective osteotomy with internal beam fixation were identified; 25 patients were included in the final analysis. Patients with a minimum 1-year follow-up were evaluated with physical examination, weightbearing radiographs, and patient-reported outcome measures. The primary outcome measure was defined as restoration of a stable, plantigrade, ulcer-free foot. Median age was 58 years, median BMI was 32, and 80% were diabetic (75% insulin-dependent).

RESULTS

: An ulcer-free, stable, plantigrade foot was obtained in 84% of patients. The radiographic lateral and anteroposterior Meary angle medians improved 9° and 15°, respectively, from preoperative to final postoperative weightbearing measurements ( P < .001 and P = .02). Overall, 46% of midfoot osteotomies were united on final radiographs at a median 18-month radiographic follow-up. Deep infection developed in 6 (24%) patients. The presence of a preoperative ulcer was found to be predictive of postoperative infection (P = .04); all 6 deep infections occurred in patients with preoperative ulceration. Four (16%) patients progressed to amputation at a mean 15 postoperative months, all for deep infection.

CONCLUSION

: Midfoot Charcot reconstruction with intramedullary beaming allowed for restoration of an ulcer-free, plantigrade foot in most patients, but the complication rates were high, especially in patients with preoperative ulceration.

LEVEL OF EVIDENCE

: Level IV, retrospective case series.

摘要

背景

本研究旨在探讨采用跖骨切开复位内固定术治疗跖骨 Ch arcot 病的临床疗效及并发症。

方法

回顾性分析 2013 年 1 月至 2016 年 7 月在我院足踝外科中心接受矫正性截骨术和髓内固定的中足 Ch arcot 患者,共纳入 25 例患者,平均随访 1 年以上,采用体格检查、负重位 X 线片和患者报告的结局测量进行评估。主要结局指标定义为获得稳定、负重、无溃疡的足部。患者平均年龄 58 岁,平均 BMI 为 32,80%为糖尿病(75%为胰岛素依赖型)。

结果

84%的患者获得无溃疡、稳定、负重的足部。与术前相比,术后负重位 X 线片上的外侧和前后 Meary 角中位数分别改善了 9°和 15°(P<0.001 和 P=0.02)。总的来说,46%的中足截骨在最终随访时(平均 18 个月)X 线片上愈合。6 例(24%)患者发生深部感染。术前溃疡的存在与术后感染相关(P=0.04);所有 6 例深部感染均发生在术前有溃疡的患者中。4 例(16%)患者因深部感染在术后 15 个月平均行截肢术。

结论

采用髓内固定治疗中足 Ch arcot 病可使大多数患者获得无溃疡、负重的足部,但并发症发生率较高,尤其是在术前有溃疡的患者。

证据等级

IV 级,回顾性病例系列。

相似文献

1
Clinical Outcomes and Complications of Midfoot Charcot Reconstruction With Intramedullary Beaming.髓内骨棒治疗中足夏科氏关节病的临床疗效和并发症。
Foot Ankle Int. 2019 Jan;40(1):18-23. doi: 10.1177/1071100718799966. Epub 2018 Oct 4.
2
Beaming in the Charcot foot: A case series with 12-month minimum follow-up.夏科氏足的影像学表现:一项至少随访12个月的病例系列研究。
Foot (Edinb). 2021 Jun;47:101814. doi: 10.1016/j.foot.2021.101814. Epub 2021 Apr 18.
3
Intramedullary medial column support with the Midfoot Fusion Bolt (MFB) is not sufficient for osseous healing of arthrodesis in neuroosteoarthropathic feet.使用中足融合螺栓(MFB)进行髓内内侧柱支撑对于神经骨关节病足关节融合的骨愈合来说是不够的。
Injury. 2014 Jan;45 Suppl 1:S38-43. doi: 10.1016/j.injury.2013.10.037. Epub 2013 Nov 1.
4
Charcot Midfoot Reconstruction: Does Subtalar Arthrodesis or Medial Column Fixation Improve Outcomes?夏科氏中足重建:距下关节融合或内侧柱固定术能改善结局吗?
J Foot Ankle Surg. 2020 Nov-Dec;59(6):1219-1223. doi: 10.1053/j.jfas.2020.07.001. Epub 2020 Jul 18.
5
Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?从中美支付者角度评估不稳定中足夏科氏神经关节病重建的成本效果
Clin Orthop Relat Res. 2020 Dec;478(12):2869-2888. doi: 10.1097/CORR.0000000000001416.
6
Solid bolt fixation of the medial column in Charcot midfoot arthropathy.夏科氏中足关节病内侧柱的实心螺栓固定
J Foot Ankle Surg. 2013 Jan-Feb;52(1):88-94. doi: 10.1053/j.jfas.2012.05.017. Epub 2012 Aug 28.
7
[Corrective arthrodesis of midfoot Charcot neuroosteoarthropathy with internal fixation].[采用内固定治疗中足夏科特神经骨关节病的矫正性关节融合术]
Oper Orthop Traumatol. 2015 Apr;27(2):139-53. doi: 10.1007/s00064-014-0338-8. Epub 2015 Apr 10.
8
Progression to Hindfoot Charcot Neuroarthropathy After Midfoot Charcot Correction in Patients With and Without Subtalar Joint Arthrodesis.中足夏科氏矫正术后足后夏科氏神经骨关节病的进展:合并与不合并距下关节融合术患者的对比。
J Foot Ankle Surg. 2023 Jul-Aug;62(4):731-736. doi: 10.1053/j.jfas.2023.03.004. Epub 2023 Mar 23.
9
Should one consider primary surgical reconstruction in charcot arthropathy of the feet?对于足部夏科氏关节病,是否应考虑初次手术重建?
Clin Orthop Relat Res. 2010 Apr;468(4):1002-11. doi: 10.1007/s11999-009-0972-x. Epub 2009 Jul 14.
10
Prediction of complications in a high-risk cohort of patients undergoing corrective arthrodesis of late stage Charcot deformity based on the PEDIS score.基于PEDIS评分对晚期夏科氏畸形矫正关节融合术高危患者并发症的预测
BMC Musculoskelet Disord. 2015 Nov 14;16:349. doi: 10.1186/s12891-015-0809-6.

引用本文的文献

1
Surgical management of the diabetic foot: The current evidence.糖尿病足的外科治疗:当前证据
World J Orthop. 2024 May 18;15(5):404-417. doi: 10.5312/wjo.v15.i5.404.
2
Outcome of Surgical Fixation for Midfoot Charcot Neuroarthropathy - A Systematic Review.中足夏科氏神经关节病手术固定的结果——一项系统评价
Malays Orthop J. 2023 Mar;17(1):27-33. doi: 10.5704/MOJ.2303.004.
3
Quality of Life Improvement Following Reconstruction of Midtarsal Charcot Foot Deformity: A Five Year Follow-Up.中跗关节夏科氏足部畸形重建后生活质量的改善:五年随访结果。
Iowa Orthop J. 2022 Jun;42(1):109-112.
4
Long-term follow-up of conservative treatment of Charcot feet.夏科氏足保守治疗的长期随访
Arch Orthop Trauma Surg. 2022 Oct;142(10):2553-2566. doi: 10.1007/s00402-021-03881-5. Epub 2021 Apr 7.
5
Outcomes of Tendo-Achilles lengthening and weight-bearing total contact cast for management of early midfoot charcot neuroarthropathy.跟腱延长术及负重全接触石膏治疗早期中足夏科氏神经关节病的疗效
J Clin Orthop Trauma. 2021 Mar 10;17:128-138. doi: 10.1016/j.jcot.2021.03.001. eCollection 2021 Jun.
6
Surgical treatment of midfoot charcot neuroarthropathy review of literature and our results after superconstruct reconstruction of midfoot charcot neuroarthropathy.中足夏科特神经关节病的外科治疗:文献综述及我们对中足夏科特神经关节病进行超结构重建后的结果
J Clin Orthop Trauma. 2021 Feb 11;17:59-64. doi: 10.1016/j.jcot.2021.02.003. eCollection 2021 Jun.
7
Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?从中美支付者角度评估不稳定中足夏科氏神经关节病重建的成本效果
Clin Orthop Relat Res. 2020 Dec;478(12):2869-2888. doi: 10.1097/CORR.0000000000001416.